Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Sulopenem Etzadroxil/Probenecid.

Hospital pharmacy·2025
Same author

Axatilimab.

Hospital pharmacy·2025
Same author

Respiratory Syncytial Virus Vaccine (mRNA).

Hospital pharmacy·2024
Same author

Resmetirom.

Hospital pharmacy·2024
Same author

Cefepime/Enmetazobactam.

Hospital pharmacy·2024
Same author

Capivasertib.

Hospital pharmacy·2024
Same journal

Stability of Diluted Intravenous Metronidazole in 0.9% Sodium Chloride.

Hospital pharmacy·2026
Same journal

Response to Comment on "Early Versus Later Anticoagulation After Ischemic Stroke in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials".

Hospital pharmacy·2026
Same journal

Significant Published Articles in 2025 for Pharmacy Nutrition Support Practice.

Hospital pharmacy·2026
Same journal

Comment on "Early Versus Later Anticoagulation After Ischemic Stroke in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials".

Hospital pharmacy·2026
Same journal

Comparison of Cystatin C-Based and Serum Creatinine-Based Renal Function Estimates Against Timed Urine Collection in Critically Ill Patients.

Hospital pharmacy·2026
Same journal

Comment on "Pharmacy Physiotherapy Interprofessional Education and Practice".

Hospital pharmacy·2026
查看所有相关文章

相关实验视频

Updated: Jun 12, 2025

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

10.5K

莱卡内马布 (Lecanemab) 是一个

Terri L Levien1, Danial E Baker1

  • 1Washington State University, Spokane, WA, USA.

Hospital pharmacy
|September 25, 2024
PubMed
概括
此摘要是机器生成的。

单式专著服务为药学和治疗委员会提供每月的药物专著,帮助药物评估和利用. 订阅者可以收到全面的评论和可定制的药房和护理人员资源.

关键词:
药物信息 药物信息 药物信息表单管理/P & T表单管理神经学 神经学 神经学

更多相关视频

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

53.2K
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.1K

相关实验视频

Last Updated: Jun 12, 2025

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

10.5K
A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

53.2K
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.1K

科学领域:

  • 药理学 药理学是指药理学的学科.
  • 药物信息服务 药物信息服务
  • 医疗保健系统 药房 药房

背景情况:

  • 药品和治疗 (P&T) 委员会需要及时准确的药物信息.
  • 评估新药和试验药物对于配方管理至关重要.
  • 有效的药物利用评估 (DUR) 和药物使用评估 (MUE) 对患者安全和成本效益至关重要.

研究的目的:

  • 介绍"表单单本书服务"作为P&T委员会资源.
  • 要突出该服务提供了关于新药和晚期试验药物的详细专著.
  • 提供关于补充资源的信息,如摘要专著和DUE/MUE.

主要方法:

  • 该服务每月提供5-6篇关于早期释放或III期试验药物的详细专著.
  • 为药房和护理服务需求提供一页的摘要专著.
  • 包括全面的药物利用评估/药物使用评估 (DUE/MUE) 报告.

主要成果:

  • 订阅者可以获得详细记录的药物信息.
  • 资源是为P&T委员会议程和员工教育量身定制的.
  • 在线访问和定制选项提高了医疗保健设施的可用性.

结论:

  • 表单单一书服务支持基于证据的表单决策.
  • 它促进了有效的药物评估和药物使用监测.
  • 该服务通过可访问,相关的药物信息来增强药房实践.